BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21448905)

  • 1. MicroRNA-328 is associated with (non-small) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration.
    Arora S; Ranade AR; Tran NL; Nasser S; Sridhar S; Korn RL; Ross JT; Dhruv H; Foss KM; Sibenaller Z; Ryken T; Gotway MB; Kim S; Weiss GJ
    Int J Cancer; 2011 Dec; 129(11):2621-31. PubMed ID: 21448905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis.
    Chen LT; Xu SD; Xu H; Zhang JF; Ning JF; Wang SF
    Med Oncol; 2012 Sep; 29(3):1673-80. PubMed ID: 22052152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-548l is involved in the migration and invasion of non-small cell lung cancer by targeting the AKT1 signaling pathway.
    Liu C; Yang H; Xu Z; Li D; Zhou M; Xiao K; Shi Z; Zhu L; Yang L; Zhou R
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):431-41. PubMed ID: 25245053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
    Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of serum miR-21 and tumor miR-200c associated with poor prognosis in patients with lung cancer.
    Liu XG; Zhu WY; Huang YY; Ma LN; Zhou SQ; Wang YK; Zeng F; Zhou JH; Zhang YK
    Med Oncol; 2012 Jun; 29(2):618-26. PubMed ID: 21516486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer.
    Wei C; Zhang R; Cai Q; Gao X; Tong F; Dong J; Hu Y; Wu G; Dong X
    Aging (Albany NY); 2019 Sep; 11(17):6734-6761. PubMed ID: 31498117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
    Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
    J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative microRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer.
    Hu L; Ai J; Long H; Liu W; Wang X; Zuo Y; Li Y; Wu Q; Deng Y
    Oncotarget; 2016 Feb; 7(8):8441-54. PubMed ID: 26870998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer.
    Yang Y; Liu L; Zhang Y; Guan H; Wu J; Zhu X; Yuan J; Li M
    Int J Cancer; 2014 Oct; 135(7):1531-42. PubMed ID: 24550137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
    Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
    Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line.
    Wang L; Qu J; Zhou L; Liao F; Wang J
    Cancer Res Treat; 2018 Jul; 50(3):936-949. PubMed ID: 29025258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
    Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
    Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic determinants of pemetrexed responsiveness and nonresponsiveness in non-small cell lung cancer cells.
    Wu MF; Hsiao YM; Huang CF; Huang YH; Yang WJ; Chan HW; Chang JT; Ko JL
    J Thorac Oncol; 2010 Aug; 5(8):1143-51. PubMed ID: 20559153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers.
    Remon J; Alvarez-Berdugo D; Majem M; Moran T; Reguart N; Lianes P
    Clin Transl Oncol; 2016 Feb; 18(2):153-9. PubMed ID: 26199015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-367 promotes tumor growth by inhibiting FBXW7 in NSCLC.
    Xiao G; Gao X; Sun X; Yang C; Zhang B; Sun R; Huang G; Li X; Liu J; Du N; Liu D; Liang R; Ren H; Qin S
    Oncol Rep; 2017 Aug; 38(2):1190-1198. PubMed ID: 28656290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation of microRNA-coding genes in non-small-cell lung cancer patients.
    Heller G; Altenberger C; Steiner I; Topakian T; Ziegler B; Tomasich E; Lang G; End-Pfützenreuter A; Zehetmayer S; Döme B; Arns BM; Klepetko W; Zielinski CC; Zöchbauer-Müller S
    J Pathol; 2018 Aug; 245(4):387-398. PubMed ID: 29570800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.